Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actions

Numerous new agents with rapid onset antidepressant effects are entering clinical trials and clinical practice. Studies focus on either first-line treatment of major depressive disorder or on patients whose major depressive disorder is resistant to prior antidepressant drugs. Novel agents target thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Takesha, Seigler, Michael David, Stahl, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076337/
https://www.ncbi.nlm.nih.gov/pubmed/36988262
http://dx.doi.org/10.1177/02698811231158891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076337/
https://www.ncbi.nlm.nih.gov/pubmed/36988262
http://dx.doi.org/10.1177/02698811231158891

Ejemplares similares